AbbVie Sets $1.55 Quarterly Dividend, Piper Sandler Ups Target by Mark Eisenberg 22.06.2024 AbbVie sets quarterly dividend at $1.55 per share, showcasing financial health and strategic growth. Recent acquisitions bolster positive outlook.
7 Breakthrough Biotech Stocks to Boost Your Portfolio in 2023 by Lilu Anderson 18.06.2024 "Discover 7 breakthrough biotech stocks poised to boost your portfolio in a sector projected to reach $521.6B by 2033. Learn ...
Tempus AI Raises $410M in IPO, Sees Revenue Surge by Mark Eisenberg 15.06.2024 Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
2 Monster Growth Stocks with Huge Potential in 2024 by Mark Eisenberg 08.04.2024 Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisition by Mark Eisenberg 01.04.2024 Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
U.S. IPO Weekly Recap: Biotech Leads Short Week by Mark Eisenberg 30.03.2024 Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
Oncology Institute Inc: Stock Price Plummets 14% by Mark Eisenberg 29.03.2024 Explore the financial update on Oncology Institute Inc amidst market fluctuations. Dive deeper into their stock performance and key financial ...
Boundless Bio Makes $100M IPO Debut on Nasdaq by Mark Eisenberg 28.03.2024 Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Moleculin Biotech Stock Coverage and Analysis at StockNews by Mark Eisenberg 28.03.2024 Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Legend Biotech Co. (NASDAQ: LEGN) Stock Position Boosted by SG Americas Securities LLC by Mark Eisenberg 27.03.2024 Lazard Asset Management and Coppell Advisory Solutions both acquired stakes in Legend Biotech. The company's stock performance had a low ...